1. Home
  2. KUKE vs CTOR Comparison

KUKE vs CTOR Comparison

Compare KUKE & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KUKE
  • CTOR
  • Stock Information
  • Founded
  • KUKE 2002
  • CTOR 2021
  • Country
  • KUKE China
  • CTOR United States
  • Employees
  • KUKE N/A
  • CTOR N/A
  • Industry
  • KUKE Other Consumer Services
  • CTOR
  • Sector
  • KUKE Real Estate
  • CTOR
  • Exchange
  • KUKE Nasdaq
  • CTOR NYSE
  • Market Cap
  • KUKE 91.9M
  • CTOR 89.9M
  • IPO Year
  • KUKE 2021
  • CTOR N/A
  • Fundamental
  • Price
  • KUKE $2.89
  • CTOR $0.86
  • Analyst Decision
  • KUKE
  • CTOR Strong Buy
  • Analyst Count
  • KUKE 0
  • CTOR 2
  • Target Price
  • KUKE N/A
  • CTOR $4.50
  • AVG Volume (30 Days)
  • KUKE 227.0K
  • CTOR 3.8M
  • Earning Date
  • KUKE 04-15-2025
  • CTOR 05-21-2025
  • Dividend Yield
  • KUKE N/A
  • CTOR N/A
  • EPS Growth
  • KUKE N/A
  • CTOR N/A
  • EPS
  • KUKE N/A
  • CTOR N/A
  • Revenue
  • KUKE $14,784,158.00
  • CTOR N/A
  • Revenue This Year
  • KUKE N/A
  • CTOR N/A
  • Revenue Next Year
  • KUKE N/A
  • CTOR N/A
  • P/E Ratio
  • KUKE N/A
  • CTOR N/A
  • Revenue Growth
  • KUKE 10.48
  • CTOR N/A
  • 52 Week Low
  • KUKE $0.15
  • CTOR $0.55
  • 52 Week High
  • KUKE $4.07
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • KUKE 68.05
  • CTOR N/A
  • Support Level
  • KUKE $2.61
  • CTOR N/A
  • Resistance Level
  • KUKE $3.27
  • CTOR N/A
  • Average True Range (ATR)
  • KUKE 0.53
  • CTOR 0.00
  • MACD
  • KUKE 0.06
  • CTOR 0.00
  • Stochastic Oscillator
  • KUKE 74.73
  • CTOR 0.00

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: